MX2022014683A - Composiciones que comprenden acidos grasos y su uso. - Google Patents

Composiciones que comprenden acidos grasos y su uso.

Info

Publication number
MX2022014683A
MX2022014683A MX2022014683A MX2022014683A MX2022014683A MX 2022014683 A MX2022014683 A MX 2022014683A MX 2022014683 A MX2022014683 A MX 2022014683A MX 2022014683 A MX2022014683 A MX 2022014683A MX 2022014683 A MX2022014683 A MX 2022014683A
Authority
MX
Mexico
Prior art keywords
fatty acids
compositions including
potential
including fatty
composition
Prior art date
Application number
MX2022014683A
Other languages
English (en)
Inventor
Nora Schneider
Jonas Hauser
Sean Deoni
Tamas Bartfai
Zolezzi Irma Silva
Tinu Mary Samuel
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MX2022014683A publication Critical patent/MX2022014683A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ink Jet (AREA)

Abstract

La presente invención se refiere a una composición que comprende uno o más derivados de ácidos grasos para usar en la promoción, apoyo u optimización de uno o más de los siguientes: (i) mielinización de novo; (ii) estructura del cerebro: (iii) conectividad del cerebro; (iv) potencial intelectual; (v) potencial cognitivo; y (vi) potencial de aprendizaje; (vii) funcionamiento cognitivo en una cría de un sujeto femenino, en donde dicha composición es para la administración al sujeto femenino.
MX2022014683A 2016-03-30 2018-09-18 Composiciones que comprenden acidos grasos y su uso. MX2022014683A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662315163P 2016-03-30 2016-03-30
US201662315142P 2016-03-30 2016-03-30
US201662315134P 2016-03-30 2016-03-30
US201662315158P 2016-03-30 2016-03-30
US201662315152P 2016-03-30 2016-03-30
US201662328094P 2016-04-27 2016-04-27
PCT/EP2016/080786 WO2017167415A1 (en) 2016-03-30 2016-12-13 Compositions comprising fatty acids and their use

Publications (1)

Publication Number Publication Date
MX2022014683A true MX2022014683A (es) 2023-01-11

Family

ID=57614346

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2018008520A MX2018008520A (es) 2016-03-30 2016-12-13 Composiciones que comprenden acidos grasos y su uso.
MX2018011336A MX2018011336A (es) 2016-03-30 2017-03-30 Composiciones que comprenden acidos grasos y su uso.
MX2022014683A MX2022014683A (es) 2016-03-30 2018-09-18 Composiciones que comprenden acidos grasos y su uso.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2018008520A MX2018008520A (es) 2016-03-30 2016-12-13 Composiciones que comprenden acidos grasos y su uso.
MX2018011336A MX2018011336A (es) 2016-03-30 2017-03-30 Composiciones que comprenden acidos grasos y su uso.

Country Status (8)

Country Link
EP (2) EP3435997A1 (es)
CN (3) CN108495627A (es)
BR (2) BR112018011412A2 (es)
CA (2) CA3003651A1 (es)
MX (3) MX2018008520A (es)
PH (2) PH12018501027A1 (es)
SG (2) SG11201803022TA (es)
WO (2) WO2017167415A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020051817A1 (zh) * 2018-09-13 2020-03-19 北京诺爱真原生物科技有限公司 一种用于先天性心脏病手术和非心脏手术后和其他重症监护婴儿营养配方奶粉及其使用方法
CN109805390A (zh) * 2019-02-27 2019-05-28 云南大学 一种神经酸钙、神经酸锌及维生素k2复合物软胶囊
CN110946099A (zh) * 2019-12-13 2020-04-03 宁波大学 一种提高双壳贝类苗种繁育产量的方法
CN113508840A (zh) * 2020-04-09 2021-10-19 北京三元食品股份有限公司 乳脂球膜在制备孕妇奶粉中的应用
CN114544821B (zh) * 2020-11-24 2023-10-24 重庆医科大学 检测血浆中磷脂酰乙醇胺（36:4）的试剂在制备抑郁症检测试剂盒中的用途
AU2023327690A1 (en) 2022-08-18 2025-01-16 Société des Produits Nestlé S.A. Kit to promote developmental myelination
CN116008438B (zh) * 2023-02-07 2023-06-06 北京三元食品股份有限公司 一种用于评价婴幼儿精细动作发育状况的标志物组及应用
WO2025252789A1 (en) 2024-06-04 2025-12-11 Société des Produits Nestlé S.A. Nutritional composition linked to brain myelination, brain structure, cognition and learning in typically developing school age children

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE84680T1 (de) 1987-12-23 1993-02-15 Nestle Sa Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels.
GB9416846D0 (en) * 1994-08-19 1994-10-12 Croda Int Plc Lipid supplementation
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
AU4555799A (en) * 1998-06-12 1999-12-30 Craig Anthony Cooney Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring
CA2371696C (en) 1999-04-29 2005-11-15 Societe Des Produits Nestle S.A. Composition for an infant formula having a low threonine content
AU2002323409A1 (en) * 2001-08-24 2003-03-10 Martek Biosciences Boulder Corporation Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
RU2007137460A (ru) * 2005-03-10 2009-04-20 Сайэл Фарма, Инк. (Us) Пищевые препараты
RU2480474C2 (ru) * 2005-04-28 2013-04-27 Энзимотек Лтд. Смеси полярных липидов, их получение и применение
AU2006251562B2 (en) * 2005-05-23 2012-03-22 Massachusetts Institute Of Technology Compositions containing PUFA and methods of use thereof
WO2008081989A1 (ja) * 2006-12-28 2008-07-10 Suntory Holdings Limited 神経再生剤
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula

Also Published As

Publication number Publication date
WO2017167899A1 (en) 2017-10-05
EP3435997A1 (en) 2019-02-06
CA3015028A1 (en) 2017-10-05
CA3003651A1 (en) 2017-10-05
PH12018550141A1 (en) 2019-03-11
MX2018011336A (es) 2019-01-31
SG11201803022TA (en) 2018-05-30
WO2017167415A1 (en) 2017-10-05
BR112018011412A2 (en) 2018-12-04
CN108495627A (zh) 2018-09-04
EP3984532A3 (en) 2022-09-21
SG11201806545WA (en) 2018-10-30
BR112018067999A2 (pt) 2019-01-15
CN108778265A (zh) 2018-11-09
MX2018008520A (es) 2018-08-16
PH12018501027A1 (en) 2019-01-28
EP3984532A2 (en) 2022-04-20
CN122005581A (zh) 2026-05-12

Similar Documents

Publication Publication Date Title
PH12018550141A1 (en) Compositions comprising fatty acids and their use
EP3984533A3 (en) Compositions comprising choline and their use
MX2022012236A (es) Composiciones que comprenden colina y su uso.
CO2017011535A2 (es) Composiciones de ácido obeticólico y métodos de uso
BR112018010335A2 (pt) composição nutricional e fórmula para bebês para promover mielinização do cérebro
UY32631A (es) Derivados de ciclopenta[c]pirrol-2-carboxilatos, su preparación y su aplicación en terapéutica.
UY33832A (es) Inhibidores de la faah.
PE20151448A1 (es) Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de quinasa pim
UY32630A (es) Derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos, su preparación y su aplicación en terapéutica.
MX2018010301A (es) Sales de derivados de piperazina obtenidas por adicion de acidos.
UY32423A (es) Derivados de azaspiranil-alquilcarbamatos de 5 eslabones, su preparacion y su aplicacion en terapeutica
EA201591545A1 (ru) C-3 алкил- и алкенил-модифицированные производные бетулиновой кислоты
MX2015007361A (es) Produccion mediada por la proteina portadora de acilo de los derivados de acidos grasos.
MX2016011290A (es) Composiciones de ester de colina de acido lipoico y metodos de uso.
MX2022012237A (es) Composiciones que comprenden fosfolipido y su uso.
MX392586B (es) Derivados de la espiropiperidina.
DOP2018000083A (es) NUEVOS DERIVADOS DE IMIDAZO[4,5-b]PIRIDINA, UN PROCESO PARA SU PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN
UY32632A (es) Derivados de ciclopenta[c]pirrolilalquilcarbamatos de heterociclos de 5 miembros, su preparación y su aplicación en terapéutica.
BR112018074061A2 (pt) composição de limpeza, método de limpeza da pele e/ou cabelo, método de fabricação de uma composição de limpeza, composição de base,. método de redução e/ou eliminação da formação de grão em uma composição de limpeza e uso de uma composição de base
CL2019001708A1 (es) Métodos para producir biomasa rica en dha, ácido palmítico y proteínas con un microorganismo eucariota.
MX2020000873A (es) Derivados de ácidos biliares marcados isotópicamente.
BR112018069629A2 (pt) processo para fazer uma composição de nanoemulsão
MX2019012327A (es) Nanoemulsiones que comprenden sulfoalquilester y/o amida de acidos grasos en fase acuosa.
PH12018501029A1 (en) Compositions comprising choline and their use
MX2018006293A (es) Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.